Donald Trump’s decision to repeal existing measures unlikely to dissuade investors from engaging with pharmaceutical companies.
Outgoing president’s “parting shot” offers further uncertainty for investors ahead of expected policy, funding rollbacks.
Margot Kane, Chief Investment Officer at Spring Point Partners, argues that lasting climate solutions require addressing wealth inequality and empowering marginalised communities.
Words may not always match actions in Trump’s second presidency, as investors are told to keep calm and carry on.
A selection of the major stories impacting ESG investors, in five easy pieces.
Low and patchy carbon prices will delay the transition to a clean economy but present political advantages, according to the Institute of...
With a new taskforce working towards developing global climate taxes, possibilities and challenges ahead are seemingly endless.
Autumn Statement criticised for supply-side focus, but promises of pension reform pique interest.
Pension fund makes case for divestment, against backdrop of increasingly positive climate policy across major markets.
In the race to net zero, Victoria Judd, Counsel at Pillsbury Winthrop Shaw Pittman, explains how the US is lapping the UK...
Subscribe to our free weekly newsletter below and never miss a story.